Otsuka Pharmaceutical is launching a virtual study to see if digital therapeutics can reduce depression symptoms.
It’s the next step in a partnership between the Tokyo-based drugmaker and Click Therapeutics, a digital health startup that is developing programs for smoking cessation, depression and insomnia. [Read more…] about Innovation in COVID times: Otsuka and Click Therapeutics announce fully virtual clinical trial, leveraging Verily’s Project Baseline
Alphabet’s X (the Google-owner’s so-called “Moonshot Factory”) published a new blog post today about Project Amber, a project it’s been working on over the past three years — the results of which it’s now making available open source for the rest of the mental health research community to learn from, and hopefully build upon. [Read more…] about Alphabet’s X shares Amber EEG system to expand the quest for mental health biomarkers
Heads-up about a couple fascinating developments over the last few weeks.
1) Verily’s Bold New Project Aims to Predict Depression Using Your Phone (SingularityHub):
“Depression is a shifting, amorphous beast that silently haunts millions. It’s also difficult to pinpoint.
Psychiatry has formulated well-tested questionnaires to diagnose depression. But these tests require patients to reach out and only provide snapshots of their disorder in time [Read more…] about Verily and LivaNova accelerate efforts to detect and treat depression
Join the disruptors of health science (Nature):
Thomas R. Insel’s biggest lesson from his shift from NIMH director to Silicon Valley entrepreneur: academic and technology company researchers should partner up.
“In early 2015, I testified with several other National Institutes of Health (NIH) directors at an annual hearing held by the US Senate. It was my 13th and final year as director of the US National Institute of Mental Health (NIMH) in Bethesda, Maryland. What struck me most was how [Read more…] about Required: Deep partnerships between industry and academia to upgrade healthcare and biomedical research via Big Data
“After serving 13 years as Director for the National Institute of Mental Health (NIMH), Thomas R. Insel, M.D., will step down effective November 1, 2015…he is definitely not retiring. He is planning to join the Google Life Sciences [Read more…] about Google gets serious about brain & mental health innovation and hires NIMH Director Tom Insel